Corvus Pharmaceuticals (CRVS) Technical (Analysis) Reports Corvus Pharmaceuticals ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Corvus Pharmaceuticals (CRVS)
Technical Analysis Report for USA stock CRVS Corvus Pharmaceuticals. Dated: 26 Aug 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock CRVS Corvus Pharmaceuticals then click here. or read Experts views on Corvus Pharmaceuticals or Forecast & share price targets of Corvus Pharmaceuticals
Corvus Pharmaceuticals Opened at 14.55 and Closed at: 14.73, which is 1.15% of previous session's close. It moved within a range of 14.34 and 15.04
The session was a Bullish session with an average volume of 692800, which is 7.3% of previous session's volumes.
- The stock has shown an up move, and its short term trend is also positive and in an uptrend.
- The stock has shown an up move, and its mid term trend is also positive and in an uptrend.
- The stock has shown an up move, and its long term trend is also positive and in an uptrend.
Support for tomorrow is 14.54 and resistance for tomorrow is 15.24
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 14.37, 14 resistance for tomorrow's hourly charts is 15.07, 15.4
10 Day SMA for Corvus Pharmaceuticals (CRVS) is 14.74 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Corvus Pharmaceuticals (CRVS) is 14.32 and the stock is trading above these levels. This is a good sign for its mid term trend
50 Day SMA for Corvus Pharmaceuticals (CRVS) is 14.17 and the stock is trading above these levels. This is a good sign for its mid to long term trend
100 Day SMA is 14.08 and the stock is trading above these levels. This is a good sign for its long term trend
200 Day SMA Corvus Pharmaceuticals is 13.63 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Corvus Pharmaceuticals is at 14.32 and 200 DMA is at 13.63, while 50 DMA and 100 DMA are at 14.17 and 14.08 respectively
Corvus Pharmaceuticals (CRVS) moving average of 20 SMA is at 14.32 and 20 EMA is at 14.41
| Date | Closing Price | 20 SMA | 20 EMA |
| 26 Wed Aug | 14.73 | 14.32 | 14.41 |
| 25 Tue Aug | 14.56 | 14.23 | 14.38 |
| 24 Mon Aug | 14.09 | 14.17 | 14.36 |
| 21 Fri Aug | 14.46 | 14.11 | 14.39 |
| 20 Thu Aug | 14.33 | 14.04 | 14.38 |
| 19 Wed Aug | 15.42 | 13.98 | 14.39 |
Corvus Pharmaceuticals (CRVS) moving average of 50 SMA is at 14.17 and 50 EMA is at 14.17
| Date | Closing Price | 50 SMA | 50 EMA |
| 26 Wed Aug | 14.73 | 14.17 | 14.17 |
| 25 Tue Aug | 14.56 | 14.11 | 14.15 |
| 24 Mon Aug | 14.09 | 14.06 | 14.13 |
| 21 Fri Aug | 14.46 | 14.01 | 14.13 |
| 20 Thu Aug | 14.33 | 13.96 | 14.12 |
| 19 Wed Aug | 15.42 | 13.89 | 14.11 |
Corvus Pharmaceuticals (CRVS) moving average of 100 SMA is at 14.08 and 100 EMA is at 13.97
| Date | Closing Price | 100 SMA | 100 EMA |
| 26 Wed Aug | 14.73 | 14.08 | 13.97 |
| 25 Tue Aug | 14.56 | 14.08 | 13.95 |
| 24 Mon Aug | 14.09 | 14.08 | 13.94 |
| 21 Fri Aug | 14.46 | 14.09 | 13.94 |
| 20 Thu Aug | 14.33 | 14.09 | 13.93 |
| 19 Wed Aug | 15.42 | 14.09 | 13.92 |
Corvus Pharmaceuticals (CRVS) moving average of 200 SMA is at 13.63 and 200 EMA is at 12.83
| Date | Closing Price | 200 SMA | 200 EMA |
| 26 Wed Aug | 14.73 | 13.63 | 12.83 |
| 25 Tue Aug | 14.56 | 13.59 | 12.81 |
| 24 Mon Aug | 14.09 | 13.56 | 12.79 |
| 21 Fri Aug | 14.46 | 13.53 | 12.78 |
| 20 Thu Aug | 14.33 | 13.49 | 12.76 |
| 19 Wed Aug | 15.42 | 13.46 | 12.74 |
Pfizer Inc has performed better than Corvus Pharmaceuticals in short term. You could have earned much better returns by investing in Pfizer Inc, about 1.93% more returns!
Corvus Pharmaceuticals has performed better than Msa Safety in short term. Holding Corvus Pharmaceuticals could be a better choice for now!
Corvus Pharmaceuticals has performed better than Glaxosmithkline Plc in short term. Holding Corvus Pharmaceuticals could be a better choice for now!
Corvus Pharmaceuticals has performed better than Davita Inc in short term. Holding Corvus Pharmaceuticals could be a better choice for now!
Corvus Pharmaceuticals has performed better than Boston Scientific in short term. Holding Corvus Pharmaceuticals could be a better choice for now!
Corvus Pharmaceuticals has performed better than Syndax Pharmaceuticals in short term. Holding Corvus Pharmaceuticals could be a better choice for now!
Scynexis Inc has performed better than Corvus Pharmaceuticals in short term. You could have earned much better returns by investing in Scynexis Inc, about 40.33% more returns!
Endra Life has performed better than Corvus Pharmaceuticals in short term. You could have earned much better returns by investing in Endra Life, about 13.96% more returns!
Corvus Pharmaceuticals has performed better than Merit Medical in short term. Holding Corvus Pharmaceuticals could be a better choice for now!
Corvus Pharmaceuticals has performed better than Livanova Plc in short term. Holding Corvus Pharmaceuticals could be a better choice for now!
Corvus Pharmaceuticals has performed better than Integra Lifesciences in short term. Holding Corvus Pharmaceuticals could be a better choice for now!
Galectin Therapeutics has performed better than Corvus Pharmaceuticals in short term. You could have earned much better returns by investing in Galectin Therapeutics, about 16.8% more returns!
Crispr Therapeutics has performed better than Corvus Pharmaceuticals in short term. You could have earned much better returns by investing in Crispr Therapeutics, about 10.59% more returns!
Cellectis S has performed better than Corvus Pharmaceuticals in short term. You could have earned much better returns by investing in Cellectis S, about 8.32% more returns!
Axogen Inc has performed better than Corvus Pharmaceuticals in short term. You could have earned much better returns by investing in Axogen Inc, about 13.06% more returns!
Atricure Inc has performed better than Corvus Pharmaceuticals in short term. You could have earned much better returns by investing in Atricure Inc, about 8.3% more returns!
Corvus Pharmaceuticals has performed better than Array Biopharma in short term. Holding Corvus Pharmaceuticals could be a better choice for now!
Akari Therapeutics has performed better than Corvus Pharmaceuticals in short term. You could have earned much better returns by investing in Akari Therapeutics, about 2.07% more returns!
Corvus Pharmaceuticals Technical analysis of indicators
Price action analysis of Corvus Pharmaceuticals (CRVS) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
ADX buy sell signal for Corvus Pharmaceuticals stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Corvus Pharmaceuticals in short term but the sell signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Corvus Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Corvus Pharmaceuticals in short term but BUY signal is weak.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Corvus Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 14.74 and Corvus Pharmaceuticals CRVS stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Corvus Pharmaceuticals CRVS stock. Volume based technical analysis of Corvus Pharmaceuticals CRVS stock is negative.
Corvus Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock CRVS Corvus Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And CRVS Experts View which covers a lot of information including buying and selling signals
CRVS future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Corvus Pharmaceuticals or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Corvus Pharmaceuticals (CRVS) Technical (Analysis) Reports Corvus Pharmaceuticals ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance


